Transcription of SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES
{{id}} {{{paragraph}}}
Example: marketing
SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES
SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES Bacillus anthracis American Society for Microbiology (ASM) Revised July, 2013 For last revision, see website below ASM Subject Matter Experts: Alice Weissfeld, James W. Snyder, Microbiology Specialists, Inc. University of Louisville Houston, TX Louisville, KY ASM SENTINEL LEVEL LABORATORY Protocol Working Group APHL Advisory Committee Vickie Baselski, University of Tennessee at Memphis Memphis, TN David Craft, Penn State Milton S. Hershey Medical Center Hershey, PA Peter H. Gilligan, University of North Carolina Hospitals/ CLINICAL Microbiology and Immunology Labs Chapel Hill, NC Larry Gray, TriHealth laboratories and University of Cincinnati College of Medicine Cincinnati, OH Major Todd Kijek, US Army Medical Research Institute for Infectious Diseases Ft.
Sentinel clinical laboratories are not required to register with the Select Agent Program to conduct diagnostic testing for Select Agents, both Tier I and non-Tier
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: